Back to first-pass browser

First-pass extracted concept

gene therapy for chronic pain

Candidate: concept label1 source documents3 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Gene therapy is described as enabling precise manipulation of pain-related genes in chronic pain. The abstract frames it as a transformative therapeutic approach rather than a specific named construct.

Source 1DOIPubMed

Resources required

The abstract states that gene therapy uses viral and non-viral delivery systems. No specific vector, payload, or protocol is named in the provided source text.

Source 1DOIPubMed

What problem it solves

It is proposed as a way to target the biological roots of pain instead of only alleviating symptoms, with the goal of reducing reliance on opioids.

Source 1DOIPubMed

What it does not solve

The abstract does not show established clinical translation and notes unresolved issues in delivery precision, safety, ethics, cost, and regulation.

Source 1DOIPubMed

Alternatives

The abstract contrasts these approaches with existing pharmacologic and interventional approaches that remain heavily reliant on opioids.

Source 1DOIPubMed

Evidence Snippets

This narrative review explores gene therapy and epigenetic modulation as transformative approaches capable of reshaping chronic pain management.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1limitationsupports2025Source 1DOIPubMed

Gene therapy and epigenetic modulation strategies for chronic pain face challenges including delivery precision, ethical and safety concerns, cost, and regulatory barriers.

Quoted textsource-backed
While promising, these strategies face challenges including delivery precision, ethical and safety concerns, cost, and regulatory barriers.
Claim 2mechanismsupports2025Source 1DOIPubMed

Gene therapy can precisely manipulate pain-related genes using viral and non-viral delivery systems to modify ion channels, neurotransmitter receptors, and inflammatory mediators implicated in neuropathic pain.

Quoted textsource-backed
Gene therapy enables precise manipulation of pain-related genes through viral and non-viral delivery systems, offering the potential to modify ion channels, neurotransmitter receptors, and inflammatory mediators implicated in neuropathic pain.
Claim 3therapeutic potentialsupports2025Source 1DOIPubMed

Gene therapy and epigenetic modulation are presented as transformative approaches for chronic pain management.

Quoted textsource-backed
This narrative review explores gene therapy and epigenetic modulation as transformative approaches capable of reshaping chronic pain management.